Galectin Therapeutics Inc.
GALT
$1.38
$0.010.73%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -11.97M | -11.22M | -12.37M | -11.49M | -10.00M |
| Total Depreciation and Amortization | 10.00K | 9.00K | 9.00K | 9.00K | 9.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.16M | 1.56M | 879.00K | 1.68M | 352.00K |
| Change in Net Operating Assets | 326.00K | 1.11M | 3.15M | -2.31M | 4.93M |
| Cash from Operations | -12.79M | -8.54M | -8.33M | -12.11M | -4.70M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 0.00 | 10.00M | 10.00M | 10.00M | 10.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 851.00K | 0.00 | 376.00K | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 851.00K | 10.00M | 10.38M | 10.00M | 10.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.94M | 1.46M | 2.04M | -2.11M | 5.30M |